Santen Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -4.56% vs -0.85% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -5.78% vs 18.41% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "72,884.00",
          "val2": "76,369.00",
          "chgp": "-4.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14,891.00",
          "val2": "16,291.00",
          "chgp": "-8.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "318.00",
          "val2": "273.00",
          "chgp": "16.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,144.00",
          "val2": "8,644.00",
          "chgp": "-5.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "141.00%",
          "val2": "154.30%",
          "chgp": "-1.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.65% vs 8.22% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 34.27% vs 278.09% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "300,004.00",
          "val2": "301,965.00",
          "chgp": "-0.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74,179.00",
          "val2": "70,081.00",
          "chgp": "5.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,083.00",
          "val2": "831.00",
          "chgp": "30.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10,140.00",
          "val2": "-15,718.00",
          "chgp": "35.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "35,844.00",
          "val2": "26,695.00",
          "chgp": "34.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "187.40%",
          "val2": "171.90%",
          "chgp": "1.55%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

72,884.00

76,369.00

-4.56%

Operating Profit (PBDIT) excl Other Income

14,891.00

16,291.00

-8.59%

Interest

318.00

273.00

16.48%

Exceptional Items

0.00

0.00

Consolidate Net Profit

8,144.00

8,644.00

-5.78%

Operating Profit Margin (Excl OI)

141.00%

154.30%

-1.33%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -4.56% vs -0.85% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -5.78% vs 18.41% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

300,004.00

301,965.00

-0.65%

Operating Profit (PBDIT) excl Other Income

74,179.00

70,081.00

5.85%

Interest

1,083.00

831.00

30.32%

Exceptional Items

-10,140.00

-15,718.00

35.49%

Consolidate Net Profit

35,844.00

26,695.00

34.27%

Operating Profit Margin (Excl OI)

187.40%

171.90%

1.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -0.65% vs 8.22% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 34.27% vs 278.09% in Mar 2024

All Annual Results